On November 2, a pharmaceutical company disclosed that the DOJ requested documents and other information related to the company’s compliance with the FCPA. The SEC is also investigating the company’s compliance with the FCPA, a fact the company disclosed in May. The SEC’s subpoena sought information about the company’s grant-making activities worldwide, specifically naming Japan, Brazil, Turkey and Russia in its request, and also addressed non-FCPA items. The company said that it plans to cooperate with DOJ’s investigation.